Meeting
2023 ASCO Annual Meeting
An interventional study of the impact of digital patient monitoring (DPM) on health outcomes, healthcare resource utilization, and feasibility of a combination with at-home treatment (tx) for delivery of systemic anticancer tx in clinical practice.
Presenter
Manfred Welslau, MD
Hospital Aschaffenburg GmbH
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Care Delivery and Regulatory Policy
Track
Care Delivery and Quality Care
Sub Track
Telemedicine/Remote Care
Clinical Trial Registration Number
NCT05694013
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr TPS1617)
DOI
10.1200/JCO.2023.41.16_suppl.TPS1617
Abstract #
TPS1617
Poster Bd #
206b
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2024 ASCO Annual Meeting
Prognostic and predictive value of ultrasensitive ctDNA monitoring in a metastatic pan-cancer cohort treated with immune checkpoint inhibitors in the context of phase 1 clinical trials.
Speaker: Rodrigo A Toledo, PhD, MBA
Videos & Slides
2024 ASCO Annual Meeting
Prescription drug monitoring program mandates and opioid prescriptions received by patients dying of cancer.
Speaker: Yuhua Bao, PhD
Videos & Slides
2024 ASCO Annual Meeting
ctDNA monitoring for breast cancer at high risk of recurrence: Interim analysis of JCOG1204A1.
Speaker: Yoichi Naito, MD
Videos & Slides
2024 ASCO Annual Meeting
Outpatient blinatumomab with digital monitoring in patients with measurable residual disease positive (MRD+) B-ALL in a phase 4 study.
Speaker: Michael Kenneth Keng, MD, FASCO